{"id":24339,"date":"2025-12-18T10:33:06","date_gmt":"2025-12-18T08:33:06","guid":{"rendered":"https:\/\/ibsal.es\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/"},"modified":"2026-08-04T12:53:47","modified_gmt":"2026-08-04T10:53:47","slug":"ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025","status":"publish","type":"post","link":"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/","title":{"rendered":"IBSAL Strengthens Its Leadership in Research with 16 Projects Funded Under the ISCIII&#8217;s Strategic Health Action 2025"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>The Salamanca Institute for Biomedical Research is receiving more than 2.7 million euros to advance research on cancer, cardiovascular diseases, neurological diseases, inflammatory diseases, and precision medicine<\/strong>.<\/p>\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\"><strong>In this call for proposals from the Carlos III Health Institute, it has also secured ten human resources grants that will help attract and retain research talent<\/strong>.<\/p>\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">The <a href=\"https:\/\/ibsal.es\/es\/\">Salamanca Biomedical Research Institute<\/a> (IBSAL) has secured funding for 16 research projects under the <strong>Strategic Health Action 2025<\/strong> (AES 2025), the main national program to promote biomedical and health research, managed by the Carlos III Health Institute (ISCIII). The total amount awarded for these projects is <strong>2,737,221 euros,<\/strong> representing significant <strong>support for the Institute\u2019s scientific activity<\/strong> and its contribution to strengthening the healthcare system. <\/p>\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">The AES is the <strong>primary public funding mechanism for health research in Spain.<\/strong> Through annual calls for proposals, the ISCIII supports the development of research and technological development projects, the training and development of research talent, and international collaboration, with the goal of promoting innovation and facilitating the transfer of knowledge to clinical and healthcare practice.<\/p>\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">In the 2025 call for proposals, IBSAL achieved <strong>a success rate of 57%,<\/strong> with 16 projects awarded out of the 28 submitted, a significant improvement over the results from 2024, when the success rate was 44% (12 awarded out of 27 applications). This increase reflects the scientific quality of the proposals submitted and the consolidation of competitive research teams aligned with the priorities of the healthcare system. The funded projects are also <strong>co-financed by the European Regional Development Fund (ERDF<\/strong>), reinforcing their impact on scientific and technological development.  <\/p>\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h4 class=\"wp-block-heading\"><strong>Current Challenges in Health Care<\/strong><\/h4>\n\n<p class=\"wp-block-paragraph\">The funded research takes a cross-disciplinary approach to some of today\u2019s major health challenges, including the study of <strong>cancer and oncohematological diseases<\/strong>, <strong>cardiovascular and metabolic disorders,<\/strong> <strong>neurological and neurodegenerative diseases<\/strong>, <strong>inflammatory and immune-mediated<\/strong> processes, as well as the development of new diagnostic and therapeutic strategies within the framework of <strong>precision medicine<\/strong>. This multidisciplinary approach reinforces IBSAL\u2019s translational nature and its commitment to generating knowledge that has a direct impact on healthcare. <\/p>\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">In addition to its research projects, IBSAL has also seen a significant boost in the area of human resources. In the <strong>AES 2025 staff recruitment calls, 10 grants were awarded<\/strong>, representing a 50% success rate\u2014an improvement over the previous year\u2019s results, which had a success rate of 47%. These grants include PFIS predoctoral contracts, M-AES mobility grants, and various positions aimed at recruiting, retaining, and expanding research activity, as well as specialized roles in bioinformatics and research management. Specifically, the following contracts were awarded: <strong>1 PFIS, 2 R\u00edo Hortega, 1 Sara Borrell, 1 Miguel Servet, 2 research intensification grants, 1 M-AES, 1 bioinformatics position, and 1 research management position.<\/strong>   <\/p>\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">Taken together, these grants <strong>solidify IBSAL\u2019s position as a center of excellence for biomedical research,<\/strong> capable of attracting and retaining talent, driving high-impact projects, and addressing major health challenges. The funding obtained will enable continued progress in research aimed at improving public health and strengthening the public research and healthcare system. <\/p>\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\"><strong>IBSAL<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">The Salamanca Institute for Biomedical Research (IBSAL) was established on March 21, 2011, through an agreement signed by the Department of Health of the Regional Government of Castile and Le\u00f3n and the University of Salamanca, which was joined in February 2012 by the Spanish National Research Council (CSIC). It is one of the 36 health research institutes accredited by the Carlos III Health Institute. <\/p>\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">Its scientific activity is organized into six areas, comprising a total of 88 research groups: Cancer (23 groups); Cardiovascular, Renal, and Respiratory (11); Neuroscience (12); Infectious, Inflammatory, and Metabolic Diseases (20); Gene and Cell Therapy and Transplants (6); and Primary Care, Public Health, and Pharmacology (16).<\/p>\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\"><strong>For more information and contact details:<\/strong><br\/><a href=\"mailto:comunicacion@ibsal.es\"><strong>comunicacion@ibsal.es<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Salamanca Institute for Biomedical Research is receiving more than 2.7 million euros to advance research on cancer, cardiovascular diseases, neurological diseases, inflammatory diseases, and precision medicine. In this call [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":24340,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[238],"tags":[240],"class_list":["post-24339","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-ibsal-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.12 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>IBSAL Strengthens Its Leadership in Research with 16 Projects Funded Under the ISCIII&#039;s Strategic Health Action 2025 | IBSAL<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IBSAL Strengthens Its Leadership in Research with 16 Projects Funded Under the ISCIII&#039;s Strategic Health Action 2025\" \/>\n<meta property=\"og:description\" content=\"The Salamanca Institute for Biomedical Research is receiving more than 2.7 million euros to advance research on cancer, cardiovascular diseases, neurological diseases, inflammatory diseases, and precision medicine. In this call [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"IBSAL\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-18T08:33:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-04T10:53:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ibsal.es\/wp-content\/uploads\/2025\/12\/CEREB_-2-scaled-e1766053973902.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1442\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sergi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sergi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\\\/\"},\"author\":{\"name\":\"Sergi\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#\\\/schema\\\/person\\\/34ba5672452d5f86b117e6cb49a6bb97\"},\"headline\":\"IBSAL Strengthens Its Leadership in Research with 16 Projects Funded Under the ISCIII&#8217;s Strategic Health Action 2025\",\"datePublished\":\"2025-12-18T08:33:06+00:00\",\"dateModified\":\"2026-08-04T10:53:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\\\/\"},\"wordCount\":607,\"image\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibsal.es\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/CEREB_-2-scaled-e1766053973902.jpg\",\"keywords\":[\"IBSAL\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\\\/\",\"url\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\\\/\",\"name\":\"IBSAL Strengthens Its Leadership in Research with 16 Projects Funded Under the ISCIII's Strategic Health Action 2025 | IBSAL\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibsal.es\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/CEREB_-2-scaled-e1766053973902.jpg\",\"datePublished\":\"2025-12-18T08:33:06+00:00\",\"dateModified\":\"2026-08-04T10:53:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#\\\/schema\\\/person\\\/34ba5672452d5f86b117e6cb49a6bb97\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ibsal.es\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/CEREB_-2-scaled-e1766053973902.jpg\",\"contentUrl\":\"https:\\\/\\\/ibsal.es\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/CEREB_-2-scaled-e1766053973902.jpg\",\"width\":2560,\"height\":1442},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibsal.es\\\/en\\\/institute-of-biomedical-research-of-salamanca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IBSAL Strengthens Its Leadership in Research with 16 Projects Funded Under the ISCIII&#8217;s Strategic Health Action 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/ibsal.es\\\/en\\\/\",\"name\":\"IBSAL\",\"description\":\"Benchmarks in translational research in biomedicine in Castilla y Le\u00f3n\",\"alternateName\":\"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibsal.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#\\\/schema\\\/person\\\/34ba5672452d5f86b117e6cb49a6bb97\",\"name\":\"Sergi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/528ac3b73275e0b7aaacef0c293ace2a4935f7e6f58f8b31465b2faf9ae5ed56?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/528ac3b73275e0b7aaacef0c293ace2a4935f7e6f58f8b31465b2faf9ae5ed56?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/528ac3b73275e0b7aaacef0c293ace2a4935f7e6f58f8b31465b2faf9ae5ed56?s=96&d=mm&r=g\",\"caption\":\"Sergi\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"IBSAL Strengthens Its Leadership in Research with 16 Projects Funded Under the ISCIII's Strategic Health Action 2025 | IBSAL","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/","og_locale":"en_US","og_type":"article","og_title":"IBSAL Strengthens Its Leadership in Research with 16 Projects Funded Under the ISCIII's Strategic Health Action 2025","og_description":"The Salamanca Institute for Biomedical Research is receiving more than 2.7 million euros to advance research on cancer, cardiovascular diseases, neurological diseases, inflammatory diseases, and precision medicine. In this call [&hellip;]","og_url":"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/","og_site_name":"IBSAL","article_published_time":"2025-12-18T08:33:06+00:00","article_modified_time":"2026-08-04T10:53:47+00:00","og_image":[{"width":2560,"height":1442,"url":"https:\/\/ibsal.es\/wp-content\/uploads\/2025\/12\/CEREB_-2-scaled-e1766053973902.jpg","type":"image\/jpeg"}],"author":"Sergi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Sergi","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/#article","isPartOf":{"@id":"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/"},"author":{"name":"Sergi","@id":"https:\/\/ibsal.es\/en\/#\/schema\/person\/34ba5672452d5f86b117e6cb49a6bb97"},"headline":"IBSAL Strengthens Its Leadership in Research with 16 Projects Funded Under the ISCIII&#8217;s Strategic Health Action 2025","datePublished":"2025-12-18T08:33:06+00:00","dateModified":"2026-08-04T10:53:47+00:00","mainEntityOfPage":{"@id":"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/"},"wordCount":607,"image":{"@id":"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/ibsal.es\/wp-content\/uploads\/2025\/12\/CEREB_-2-scaled-e1766053973902.jpg","keywords":["IBSAL"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/","url":"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/","name":"IBSAL Strengthens Its Leadership in Research with 16 Projects Funded Under the ISCIII's Strategic Health Action 2025 | IBSAL","isPartOf":{"@id":"https:\/\/ibsal.es\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/#primaryimage"},"image":{"@id":"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/ibsal.es\/wp-content\/uploads\/2025\/12\/CEREB_-2-scaled-e1766053973902.jpg","datePublished":"2025-12-18T08:33:06+00:00","dateModified":"2026-08-04T10:53:47+00:00","author":{"@id":"https:\/\/ibsal.es\/en\/#\/schema\/person\/34ba5672452d5f86b117e6cb49a6bb97"},"breadcrumb":{"@id":"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/#primaryimage","url":"https:\/\/ibsal.es\/wp-content\/uploads\/2025\/12\/CEREB_-2-scaled-e1766053973902.jpg","contentUrl":"https:\/\/ibsal.es\/wp-content\/uploads\/2025\/12\/CEREB_-2-scaled-e1766053973902.jpg","width":2560,"height":1442},{"@type":"BreadcrumbList","@id":"https:\/\/ibsal.es\/en\/ibsal-strengthens-its-leadership-in-research-with-16-projects-funded-under-the-isciiis-strategic-health-action-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibsal.es\/en\/institute-of-biomedical-research-of-salamanca\/"},{"@type":"ListItem","position":2,"name":"IBSAL Strengthens Its Leadership in Research with 16 Projects Funded Under the ISCIII&#8217;s Strategic Health Action 2025"}]},{"@type":"WebSite","@id":"https:\/\/ibsal.es\/en\/#website","url":"https:\/\/ibsal.es\/en\/","name":"IBSAL","description":"Benchmarks in translational research in biomedicine in Castilla y Le\u00f3n","alternateName":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibsal.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ibsal.es\/en\/#\/schema\/person\/34ba5672452d5f86b117e6cb49a6bb97","name":"Sergi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/528ac3b73275e0b7aaacef0c293ace2a4935f7e6f58f8b31465b2faf9ae5ed56?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/528ac3b73275e0b7aaacef0c293ace2a4935f7e6f58f8b31465b2faf9ae5ed56?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/528ac3b73275e0b7aaacef0c293ace2a4935f7e6f58f8b31465b2faf9ae5ed56?s=96&d=mm&r=g","caption":"Sergi"}}]}},"_links":{"self":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/posts\/24339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/comments?post=24339"}],"version-history":[{"count":1,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/posts\/24339\/revisions"}],"predecessor-version":[{"id":24341,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/posts\/24339\/revisions\/24341"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/media\/24340"}],"wp:attachment":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/media?parent=24339"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/categories?post=24339"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tags?post=24339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}